Literature DB >> 27073657

Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration.

Azusa Tanimoto1, Shinji Takeuchi1, Hiroshi Yaegashi2, Hiroshi Kotani1, Hidenori Kitai1, Shigeki Nanjo1, Hiromichi Ebi1, Kaname Yamashita1, Hisatsugu Mouri1, Koushiro Ohtsubo1, Hiroko Ikeda3, Seiji Yano1.   

Abstract

A 76-year-old female in whom a renal cell carcinoma (RCC) lesion was resected 19 years previously presented to our hospital with cognitive dysfunction. Magnetic resonance imaging and computed tomography revealed nodules in the brain, lung, adrenal gland and a pelvic osteolytic lesion. To identify the primary cancer site, the present study performed endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of the left adrenal lesion. Consequently, the pathological findings of the tissue obtained by EUS-FNA were similar to those of the previous nephrectomy specimen, revealing that the adrenal lesion was the recurrence of RCC. The majority of the metastatic lesions in the patient were reduced in size by the multiple kinase inhibitor, pazopanib. Contralateral adrenal metastasis of RCC is rare and the use of EUS-FNA in the diagnosis of adrenal lesions remains to be elucidated. This is a rare case of adrenal lesion, diagnosed by EUS-FNA. Therefore, EUS-FNA is considered to be a useful diagnostic modality of adrenal metastases from unidentified primary tumor types.

Entities:  

Keywords:  contralateral adrenal metastasis; endoscopic ultrasound-guided fine-needle aspiration; late recurrence; pazopanib; renal cell carcinoma

Year:  2016        PMID: 27073657      PMCID: PMC4812346          DOI: 10.3892/mco.2016.739

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  15 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer.

Authors:  Noriomi Miyao; Seiji Naito; Seiichiro Ozono; Nobuo Shinohara; Naoya Masumori; Tatsuo Igarashi; Masahiro Nakao; Tomoyasu Tsushima; Yutaka Senga; Shigeo Horie; Hiro-omi Kanayama; Noriaki Tokuda; Mikio Kobayashi
Journal:  Urology       Date:  2010-10-23       Impact factor: 2.649

3.  Surveillance strategies for renal cell carcinoma patients following nephrectomy.

Authors:  Arnold I Chin; John S Lam; Robert A Figlin; Arie S Belldegrun
Journal:  Rev Urol       Date:  2006

Review 4.  Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses.

Authors:  Shigetaka Yoshinaga; Haruhisa Suzuki; Ichiro Oda; Yutaka Saito
Journal:  Dig Endosc       Date:  2011-05       Impact factor: 7.559

5.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Authors:  G H Mickisch; A Garin; H van Poppel; L de Prijck; R Sylvester
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

6.  Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.

Authors:  W K Lau; H Zincke; C M Lohse; J C Cheville; A L Weaver; M L Blute
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

7.  EUS-FNA of the left adrenal gland is safe and useful.

Authors:  Tiing Leong Ang; Tju Siang Chua; Kwong Ming Fock; Augustine K H Tee; Eng Kiong Teo; Kent Mancer
Journal:  Ann Acad Med Singapore       Date:  2007-11       Impact factor: 2.473

8.  Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients.

Authors:  Nirag C Jhala; Darshana Jhala; Mohamad A Eloubeidi; David C Chhieng; D Ralph Crowe; Janie Roberson; Isam Eltoum
Journal:  Cancer       Date:  2004-10-25       Impact factor: 6.860

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

Review 10.  Renal cell carcinoma.

Authors:  Eric Jonasch; Jianjun Gao; W Kimryn Rathmell
Journal:  BMJ       Date:  2014-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.